Skip to main content
Teri Lyng

Teri Lyng

The health of the world socially, and environmentally, directly affects the health of people. This very simple premise is what truly aligns Haleon’s ESG strategy with our purpose – to deliver better everyday health with humanity.”

— Teri Lyng

Teri was appointed as Head of Transformation and Sustainability in 2019, while the business was still part of GSK. Teri led our Transformation office which managed the integration of the Pfizer Consumer Healthcare business and the subsequent separation programme to demerge Haleon from GSK. She has been responsible for the development and execution of the ESG Strategy and embedding it into our culture and business.   

Previously, Teri led the Quality function for GSK Consumer Healthcare and before that held similar roles in the OTC division at Novartis and the Consumer Health Divisions of both Wyeth and Merck.

Favourite brand: Pronamel